TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03295604 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02589028 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00139984 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02100930 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00939510 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00399607 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04002622 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03343678 — Surrogate Endpoint (SUR): Minimal residual disease response rate
Study NCT04407156 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02730923 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01858831 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03966898 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03966898 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00780949 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study NCT04379297 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00999167 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT00996879 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04629625 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study NCT03088787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05272397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03732716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02008149 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02244372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02244372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02315703 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02888860 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT00899418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00899418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00899418 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03008070 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03485950 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02782351 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01941654 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04619290 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT02453750 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00095472 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04105192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01042067 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03419572 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03419572 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02717117 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02717117 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01952769 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03101930 — Predictive Biomarker (PRD): GLP1R mRNA
Genes: GLP1R
Study NCT04899726 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02353858 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01316731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00976495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00535535 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00001901 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02776605 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02776605 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02682459 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04452123 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03047967 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01423695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00074919 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01996631 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03628235 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01447745 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05131412 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03238703 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03238703 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00317486 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04281420 — Predictive Biomarker (PRD): PAK4 mRNA
Genes: PAK4; KIAA1142
Study NCT04281420 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study NCT00719992 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00295282 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT02057939 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01392638 — Predictive Biomarker (PRD): NANOS3 mRNA
Genes: NANOS3; NOS3
Study NCT03323216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00652743 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00205153 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00043745 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01150786 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04556357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02967419 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT02967419 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02967419 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03237416 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02869178 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT02902445 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study NCT02902445 — Predictive Biomarker (PRD): FUT3 mRNA
Genes: FUT3; FT3B; LE
Study NCT01094184 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01094184 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04307511 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT03692780 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00749788 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03159273 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01657604 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01657604 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02821156 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00414323 — Predictive Biomarker (PRD): NE
Study NCT04045938 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01989741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03481816 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00714662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03282344 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT05568810 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT03820336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02471534 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01508559 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01413295 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01413295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01279291 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00651014 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04412317 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01646749 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT04312477 — Predictive Biomarker (PRD): INAVA mRNA
Genes: INAVA; C1orf106
Study NCT04312477 — Predictive Biomarker (PRD): ARF6 mRNA
Genes: ARF6
Study NCT00556439 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02798744 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00055926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00175565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00175565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00693446 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT01059864 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01059864 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01053598 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04649021 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03370211 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04425174 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03345901 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study NCT00216138 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02137876 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05233501 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT06090123 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04311112 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT04311112 — Predictive Biomarker (PRD): LRAT mRNA
Genes: LRAT
Study NCT00722046 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00402896 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00402896 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00402896 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03039244 — Safety Biomarker (SAF): Interleukin 1
Study NCT03039244 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT03039244 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03039244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01936051 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT02089763 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT02089763 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT02656966 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01234038 — Predictive Biomarker (PRD): EIF4E mRNA
Genes: EIF4E; EIF4EL1; EIF4F
Study NCT04251832 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03113617 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT02428673 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05447390 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02704624 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02704624 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00329823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03320837 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT03390296 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00411151 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00411151 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00411151 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00411151 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT00411151 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00411151 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02213744 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00005181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04293276 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04293276 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01244035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02644889 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02644889 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04916561 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04916561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03275090 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03275090 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT00400218 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04648917 — Predictive Biomarker (PRD): KDM4C mRNA
Genes: KDM4C; GASC1; JHDM3C; JMJD2C; KIAA0780
Study NCT02567656 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04388215 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04388215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04863053 — Predictive Biomarker (PRD): PTGS1 mRNA
Genes: PTGS1; COX1
Study NCT04863053 — Predictive Biomarker (PRD): TBXA2R mRNA
Genes: TBXA2R
Study NCT03689569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03689569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03689569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00290719 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03012191 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT00847899 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01109615 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00006786 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01315613 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT05290506 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02051751 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01040689 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01654874 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00049322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00049322 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04538599 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT02151903 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03136653 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03136653 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03136653 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03136653 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02015949 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00068926 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02492308 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02750046 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02655757 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01784679 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT00517010 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03513367 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04014439 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00265837 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01162473 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00124072 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00589706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00589706 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00369850 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01295151 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01814865 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03094169 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03636334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03791593 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03791593 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT00996957 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01169701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04373148 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03299244 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT03299244 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04460807 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04460807 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00809926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04169204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04848168 — Predictive Biomarker (PRD): PIM2 mRNA
Genes: PIM2
Study NCT00848237 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT02454530 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02454530 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT02805816 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03026816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01510990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01510990 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01382849 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02058108 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02930954 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01637532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01864317 — Predictive Biomarker (PRD): GPSM2 mRNA
Genes: GPSM2; LGN
Study NCT02509364 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01664117 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04781790 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study NCT02576548 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04014699 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00245388 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00245388 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03965104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01384565 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01384565 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01384565 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01384565 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01384565 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01384565 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01384565 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04120246 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00358319 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01558115 — Surrogate Endpoint (SUR): Bone mineral density